Companies / Freenome
Freenome is developing blood-based screening tests that use multiomics, artificial intelligence and machine learning to detect cancer at its earliest, most treatable stages. It serves health systems, providers and patients.
Summarized from its homepage on 4 Nov 2026.
Vendors of Freenome and the evidence for each
Freenome declares 5 subprocessors.
VendorCategoryEvidenceLevel
Google WorkspaceProductivityConfirmed
Google CloudCloud and infrastructureConfirmed
GitLabDeveloper toolsConfirmed
RedoxConfirmed
ServalConfirmed
CloudflareCloud and infrastructureLikely
FastlyCloud and infrastructureLikely
Google Tag ManagerAnalyticsLikely
Website
Companies using Google Tag Managerscript: .src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f11 Nov 2026Source
GreenhouseHRLikely
OneTrustSecurity and identityLikely
10 more vendors
See Freenome's full stack and the source for every claim.
Create a free accountWork email, no card. Already have one? Log inVendor's own statement, retrieved from the source URL on the date shown. StrataDB does not verify the underlying claim. Data sources.
See Freenome's full stack
Every vendor with its source and date, and an alert when Freenome adds or drops one. The same lookup works for any company.
- Every company and vendor, with its public source
- 100 API calls a month, plus MCP and the Chrome extension
- Work email only. No card, no sales call